| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
| 1 | Adrenergic signaling in cardiomyocytes 1 gene, 1 drug (DrugBank), 13 diseases shown |
[1] ADRB2 |
D02147 |
Salbutamol |
[13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
| 2 | Alanine, aspartate and glutamate metabolism 4 genes, 1 drug (DrugBank), 14 diseases shown |
[4] ABAT, ALDH5A1, GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 3 | Alcoholism 5 genes, 1 drug (DrugBank), 7 diseases shown |
[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| 4 | Aldosterone synthesis and secretion 3 genes, 1 drug (DrugBank), 14 diseases shown |
[3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 5 | Alzheimer disease 5 genes, 1 drug (DrugBank), 7 diseases shown |
[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| 6 | Amphetamine addiction 9 genes, 1 drug (DrugBank), 7 diseases shown |
[9] GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| 7 | Amyotrophic lateral sclerosis (ALS) 7 genes, 1 drug (DrugBank), 7 diseases shown |
[7] GRIA1, GRIA2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| 8 | Arachidonic acid metabolism 2 genes, 2 drugs (DrugBank), 17 diseases shown |
[2] PTGS1, PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| [1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 9 | beta-Alanine metabolism 3 genes, 1 drug (DrugBank), 14 diseases shown |
[3] ABAT, GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 10 | Butanoate metabolism 4 genes, 1 drug (DrugBank), 14 diseases shown |
[4] ABAT, ALDH5A1, GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 11 | C-type lectin receptor signaling pathway 1 gene, 2 drugs (DrugBank), 17 diseases shown |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 12 | Calcium signaling pathway 9 genes, 4 drugs (DrugBank), 26 diseases shown |
[1] ADRB2 |
D02147 |
Salbutamol |
[13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
| [3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| [4] GRIN1, GRIN2A, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| [1] TNNC2 |
D11363 |
Reldesemtiv |
[2] 2, 3 |
| 13 | cAMP signaling pathway 10 genes, 2 drugs (DrugBank), 18 diseases shown |
[1] ADRB2 |
D02147 |
Salbutamol |
[13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
| [9] GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| 14 | cGMP-PKG signaling pathway 1 gene, 1 drug (DrugBank), 13 diseases shown |
[1] ADRB2 |
D02147 |
Salbutamol |
[13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
| 15 | Chemical carcinogenesis 1 gene, 2 drugs (DrugBank), 17 diseases shown |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 16 | Cholinergic synapse 1 gene, 1 drug (DrugBank), 4 diseases shown |
[1] ACHE |
D00487 |
Pyridostigmine |
[4] 3, 6, 11, 256 |
| 17 | Circadian entrainment 12 genes, 2 drugs (DrugBank), 17 diseases shown |
[3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| [9] GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| 18 | Cocaine addiction 6 genes, 1 drug (DrugBank), 7 diseases shown |
[6] GRIA2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| 19 | Cortisol synthesis and secretion 4 genes, 3 drugs (DrugBank), 18 diseases shown |
[3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| [1] KCNA4 |
D10228 |
Amifampridine |
[3] 3, 11, 12 |
| D04127 |
Dalfampridine |
[3] 3, 4, 13 |
| 20 | Cushing syndrome 4 genes, 3 drugs (DrugBank), 18 diseases shown |
[3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| [1] KCNA4 |
D10228 |
Amifampridine |
[3] 3, 11, 12 |
| D04127 |
Dalfampridine |
[3] 3, 4, 13 |
| 21 | Cytokine-cytokine receptor interaction 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] GHR |
D02691 |
Somatotropin |
[18] 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| 22 | Dopaminergic synapse 6 genes, 1 drug (DrugBank), 7 diseases shown |
[6] GRIA1, GRIA2, GRIA3, GRIA4, GRIN2A, GRIN2B |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| 23 | Drug metabolism - other enzymes 1 gene, 1 drug (DrugBank), 8 diseases shown |
[1] RRM2 |
D00341 |
Hydroxyurea |
[8] 3, 13, 19, 20, 65, 85, 86, 284 |
| 24 | GABAergic synapse 19 genes, 2 drugs (DrugBank), 22 diseases shown |
[3] ABAT, GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
[10] 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| 25 | Glutamatergic synapse 14 genes, 1 drug (DrugBank), 7 diseases shown |
[14] GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| 26 | Glutathione metabolism 1 gene, 1 drug (DrugBank), 8 diseases shown |
[1] RRM2 |
D00341 |
Hydroxyurea |
[8] 3, 13, 19, 20, 65, 85, 86, 284 |
| 27 | Glycerophospholipid metabolism 1 gene, 1 drug (DrugBank), 4 diseases shown |
[1] ACHE |
D00487 |
Pyridostigmine |
[4] 3, 6, 11, 256 |
| 28 | GnRH secretion 3 genes, 1 drug (DrugBank), 14 diseases shown |
[3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 29 | GnRH signaling pathway 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] GNRHR |
D00989 |
Leuprolide |
[5] 1, 2, 3, 51, 76 |
| 30 | Growth hormone synthesis, secretion and action 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] GHR |
D02691 |
Somatotropin |
[18] 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| 31 | Human cytomegalovirus infection 1 gene, 2 drugs (DrugBank), 17 diseases shown |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 32 | Human papillomavirus infection 1 gene, 2 drugs (DrugBank), 17 diseases shown |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 33 | Huntington disease 2 genes, 1 drug (DrugBank), 7 diseases shown |
[2] GRIN1, GRIN2B |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| 34 | IL-17 signaling pathway 1 gene, 2 drugs (DrugBank), 17 diseases shown |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 35 | JAK-STAT signaling pathway 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] GHR |
D02691 |
Somatotropin |
[18] 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| 36 | Kaposi sarcoma-associated herpesvirus infection 1 gene, 2 drugs (DrugBank), 17 diseases shown |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 37 | Leishmaniasis 1 gene, 2 drugs (DrugBank), 17 diseases shown |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 38 | Long-term depression 3 genes, 1 drug (DrugBank), 7 diseases shown |
[3] GRIA1, GRIA2, GRIA3 |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| 39 | Long-term potentiation 7 genes, 1 drug (DrugBank), 7 diseases shown |
[7] GRIA1, GRIA2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| 40 | MAPK signaling pathway 3 genes, 1 drug (DrugBank), 14 diseases shown |
[3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 41 | Metabolic pathways 7 genes, 4 drugs (DrugBank), 30 diseases shown |
[4] ABAT, ALDH5A1, GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| [2] PTGS1, PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| [1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| [1] RRM2 |
D00341 |
Hydroxyurea |
[8] 3, 13, 19, 20, 65, 85, 86, 284 |
| 42 | MicroRNAs in cancer 1 gene, 2 drugs (DrugBank), 17 diseases shown |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 43 | Morphine addiction 16 genes, 1 drug (DrugBank), 10 diseases shown |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
[10] 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| 44 | Neuroactive ligand-receptor interaction 33 genes, 5 drugs (DrugBank), 38 diseases shown |
[1] ADRB2 |
D02147 |
Salbutamol |
[13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
| [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
[10] 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| [1] GHR |
D02691 |
Somatotropin |
[18] 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| [1] GNRHR |
D00989 |
Leuprolide |
[5] 1, 2, 3, 51, 76 |
| [14] GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| 45 | NF-kappa B signaling pathway 1 gene, 2 drugs (DrugBank), 17 diseases shown |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 46 | Nicotine addiction 25 genes, 2 drugs (DrugBank), 14 diseases shown |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
[10] 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| [9] GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| 47 | Oocyte meiosis 1 gene, 1 drug (DrugBank), 7 diseases shown |
[1] AR |
D00075 |
Testosterone |
[7] 1, 2, 3, 13, 78, 113, 265 |
| D00957 |
| D00958 |
| D00959 |
| D06085 |
| D06087 |
| 48 | Ovarian steroidogenesis 1 gene, 2 drugs (DrugBank), 17 diseases shown |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 49 | Oxytocin signaling pathway 1 gene, 2 drugs (DrugBank), 17 diseases shown |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 50 | p53 signaling pathway 1 gene, 1 drug (DrugBank), 8 diseases shown |
[1] RRM2 |
D00341 |
Hydroxyurea |
[8] 3, 13, 19, 20, 65, 85, 86, 284 |
| 51 | Pathways in cancer 2 genes, 3 drugs (DrugBank), 21 diseases shown |
[1] AR |
D00075 |
Testosterone |
[7] 1, 2, 3, 13, 78, 113, 265 |
| D00957 |
| D00958 |
| D00959 |
| D06085 |
| D06087 |
| [1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 52 | PI3K-Akt signaling pathway 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] GHR |
D02691 |
Somatotropin |
[18] 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| 53 | Platelet activation 1 gene, 1 drug (DrugBank), 13 diseases shown |
[1] PTGS1 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| 54 | Propanoate metabolism 1 gene, 1 drug (DrugBank), 14 diseases shown |
[1] ABAT |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 55 | Prostate cancer 1 gene, 1 drug (DrugBank), 7 diseases shown |
[1] AR |
D00075 |
Testosterone |
[7] 1, 2, 3, 13, 78, 113, 265 |
| D00957 |
| D00958 |
| D00959 |
| D06085 |
| D06087 |
| 56 | Purine metabolism 1 gene, 1 drug (DrugBank), 8 diseases shown |
[1] RRM2 |
D00341 |
Hydroxyurea |
[8] 3, 13, 19, 20, 65, 85, 86, 284 |
| 57 | Pyrimidine metabolism 1 gene, 1 drug (DrugBank), 8 diseases shown |
[1] RRM2 |
D00341 |
Hydroxyurea |
[8] 3, 13, 19, 20, 65, 85, 86, 284 |
| 58 | Rap1 signaling pathway 3 genes, 1 drug (DrugBank), 7 diseases shown |
[3] GRIN1, GRIN2A, GRIN2B |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| 59 | Ras signaling pathway 3 genes, 1 drug (DrugBank), 7 diseases shown |
[3] GRIN1, GRIN2A, GRIN2B |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| 60 | Regulation of lipolysis in adipocytes 3 genes, 3 drugs (DrugBank), 23 diseases shown |
[1] ADRB2 |
D02147 |
Salbutamol |
[13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
| [2] PTGS1, PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| [1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 61 | Renin secretion 1 gene, 1 drug (DrugBank), 13 diseases shown |
[1] ADRB2 |
D02147 |
Salbutamol |
[13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
| 62 | Retrograde endocannabinoid signaling 21 genes, 4 drugs (DrugBank), 23 diseases shown |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
[10] 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| [4] GRIA1, GRIA2, GRIA3, GRIA4 |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| [1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 63 | RNA transport 1 gene, 2 drugs (DrugBank), 1 disease shown |
[1] SMN2 |
D10881 |
Nusinersen |
[1] 3 |
| D11406 |
Risdiplam |
[1] 3 |
| 64 | Salivary secretion 1 gene, 1 drug (DrugBank), 13 diseases shown |
[1] ADRB2 |
D02147 |
Salbutamol |
[13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
| 65 | Serotonergic synapse 6 genes, 5 drugs (DrugBank), 22 diseases shown |
[3] GABRB1, GABRB2, GABRB3 |
D00550 |
Midazolam |
[10] 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| [1] KCND2 |
D10228 |
Amifampridine |
[3] 3, 11, 12 |
| D04127 |
Dalfampridine |
[3] 3, 4, 13 |
| [2] PTGS1, PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| [1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 66 | Small cell lung cancer 1 gene, 2 drugs (DrugBank), 17 diseases shown |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 67 | Systemic lupus erythematosus 2 genes, 1 drug (DrugBank), 7 diseases shown |
[2] GRIN2A, GRIN2B |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| 68 | Taste transduction 6 genes, 1 drug (DrugBank), 10 diseases shown |
[6] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 |
D00550 |
Midazolam |
[10] 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| 69 | Taurine and hypotaurine metabolism 2 genes, 1 drug (DrugBank), 14 diseases shown |
[2] GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 70 | TNF signaling pathway 1 gene, 2 drugs (DrugBank), 17 diseases shown |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 71 | Transcriptional misregulation in cancer 1 gene, 1 drug (DrugBank), 7 diseases shown |
[1] GRIA3 |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| 72 | Type I diabetes mellitus 2 genes, 1 drug (DrugBank), 14 diseases shown |
[2] GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 73 | Type II diabetes mellitus 1 gene, 1 drug (DrugBank), 14 diseases shown |
[1] CACNA1G |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 74 | Valine, leucine and isoleucine degradation 1 gene, 1 drug (DrugBank), 14 diseases shown |
[1] ABAT |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 75 | VEGF signaling pathway 1 gene, 2 drugs (DrugBank), 17 diseases shown |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |